相关实验视频

Updated: Jun 29, 2025

$Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain$

Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain

Published on: May 10, 2017

一名沙特妇女用Ceftriaxone诱导固定药物喷发

Rehab Y Al-Ansari¹, Leena Abdulrahman Almuhaish², Khaled Abdullah Hassan³

¹Adult Hematology Unit, Internal Medicine Department, King Fahd Military Medical Complex, Dhahran, Saudi Arabia.

Case reports in dermatological medicine

|March 25, 2024

概括

本案例报告详细介绍了一例罕见的沙特妇女因抗生素 ceftriaxone引起的复发性固定药物喷发 (FDE) 的情况. 它强调了认识到这种不良药物反应对患者安全的重要性.

科学领域:

免疫学免疫学免疫学
药理学药理学是指药理学的学科.
皮肤病学皮肤病学

背景情况:

固定的药物喷发 (FDE) 是一种免疫介导的皮肤对药物的反应,其特征是同一部位的反复病变.
塞夫特里亚克松是一种第三代类抗生素,它对格拉姆阴性细菌有效,但很少引起FDE.
本报告记录了沙特阿拉伯第一个因塞夫特里亚引起的复发性FDE病例,也是全球第五个病例.

研究的目的:

报告一种罕见的复发性固定药物喷发 (FDE) 的临床病例,由 ceftriaxone 引起.
突出识别 ceftriaxone 触发的 FDE 的重要性,特别是在没有先前过敏史的患者中.
为学术和研究目的强调理解反复出现的FDE机制的重要性.

主要方法:

一个案例报告,一名25岁的沙特妇女患有状细胞贫血,经历了复发性的FDE.
在服用 ceftriaxone 后对病变发展的临床观察.
检查患者病史和以前的药物暴露情况.

主要成果:

患者在接受治疗呼吸道感染的塞夫triaxone后,在她的背上出现了唇和7x11厘米的FDE.
在之前没有注意到过色素病变的部位出现FDE的复发,该病变是由于Ceftriaxone在一年前被给予的.
这种反应被诊断为 ceftriaxone 诱导的 FDE,并开始使用类固醇和抗胰岛素治疗.

结论:

塞夫特里亚克森可以诱导固定药物喷发,这些喷发可能会在先前受影响的部位复发.
这一案例强调了彻底的药物病史的重要性,即使没有报告过敏.
对复发性FDE的机制进行进一步研究是必不可少的.

更多相关视频

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

相关概念视频

Dosage Regimen: Fixed Dose

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

Allergic Drug Reactions

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...